Ivermectin iverheal (https://www.medsvilla.com/iverheal-12mg/) was originally developed in the late 1970s as an anti-parasitic drug for veterinary use. It became widely known for its effectiveness against nematodes and ectoparasites in animals. In 1987, it was approved for human use to treat onchocerciasis (river blindness), a parasitic disease caused by Onchocerca volvulus. It later gained approval for treating other parasitic infections such as strongyloidiasis, scabies, and lice. Its success in controlling neglected tropical diseases earned it global recognition and a Nobel Prize in Physiology or Medicine in 2015 for its role in improving global health.